y
Basic Information | |
---|---|
Species | Glycine max |
Cazyme ID | Glyma13g23010.1 |
Family | GT47 |
Protein Properties | Length: 526 Molecular Weight: 60948.6 Isoelectric Point: 10.0744 |
Chromosome | Chromosome/Scaffold: 13 Start: 26479058 End: 26482887 |
Description | Exostosin family protein |
View CDS |
External Links |
---|
NCBI Taxonomy |
Plaza |
CAZyDB |
Signature Domain Download full data set without filtering | |||
---|---|---|---|
Family | Start | End | Evalue |
GT47 | 188 | 474 | 0 |
KRFKVWVYEEGEQPLVHYGPVNNIYSIEGQFIDEMDNYHKWSHFRARNPNQAHVFLIPFSIVNIVQYVYNRNLRQPGSQSIQLLVEDYIRVIAHKYPYWN RTEGADHFLLSCHDWGPTISYANPKLFKNFIRVLCNANTSEGFRPNKDVSIPEVNLLPRGTLGSPNRGQHPNDRTILAFFAGREHGAIRTILLNHWKDKD NDVQIYESLPKGKVYTKLMGQSKFCLCPSGYEVASPRVVEAIYAGCVPVLISSSYSPPFTDVLNWSQFSVEIPVEKIPEIKTILQSV |
Full Sequence |
---|
Protein Sequence Length: 526 Download |
MSLDKFLTVR LNLNYHFHVF IYTIETIRQR LSKLKAMEWF RCPVSGLLLP LFFFLAFFIF 60 FPRKEQNYVT HLPPPSFLST IKLNHTNITT FSPSPLPQPP PPPPLELLSI FAPANESYNN 120 TSTVLSGVIK KYPSLDKIEE GLARARASIR ESARFINYTS PTREKIVPKR SIYWNARAFH 180 QSQKEMLKRF KVWVYEEGEQ PLVHYGPVNN IYSIEGQFID EMDNYHKWSH FRARNPNQAH 240 VFLIPFSIVN IVQYVYNRNL RQPGSQSIQL LVEDYIRVIA HKYPYWNRTE GADHFLLSCH 300 DWGPTISYAN PKLFKNFIRV LCNANTSEGF RPNKDVSIPE VNLLPRGTLG SPNRGQHPND 360 RTILAFFAGR EHGAIRTILL NHWKDKDNDV QIYESLPKGK VYTKLMGQSK FCLCPSGYEV 420 ASPRVVEAIY AGCVPVLISS SYSPPFTDVL NWSQFSVEIP VEKIPEIKTI LQSVSPKKYL 480 KLQMNVLRVQ RHFTINRPAK PFDLMHMILH SIWLRRLNLK LVDSR* 540 |
Functional Domains Download unfiltered results here | ||||||||
---|---|---|---|---|---|---|---|---|
Cdd ID | Domain | E-Value | Start | End | Length | Domain Description | ||
pfam03016 | Exostosin | 1.0e-64 | 186 | 474 | 307 | + Exostosin family. The EXT family is a family of tumour suppressor genes. Mutations of EXT1 on 8q24.1, EXT2 on 11p11-13, and EXT3 on 19p have been associated with the autosomal dominant disorder known as hereditary multiple exostoses (HME). This is the most common known skeletal dysplasia. The chromosomal locations of other EXT genes suggest association with other forms of neoplasia. EXT1 and EXT2 have both been shown to encode a heparan sulphate polymerase with both D-glucuronyl (GlcA) and N-acetyl-D-glucosaminoglycan (GlcNAC) transferase activities. The nature of the defect in heparan sulphate biosynthesis in HME is unclear. |
Gene Ontology | |
---|---|
GO Term | Description |
GO:0016020 | membrane |
Annotations - NR Download unfiltered results here | |||||||
---|---|---|---|---|---|---|---|
Source | Hit ID | E-Value | Query Start | Query End | Hit Start | Hit End | Description |
GenBank | ABP03872.1 | 0 | 104 | 521 | 58 | 465 | Exostosin-like [Medicago truncatula] |
GenBank | ABP03873.1 | 0 | 126 | 525 | 228 | 617 | Exostosin-like [Medicago truncatula] |
EMBL | CBI25537.1 | 0 | 117 | 521 | 70 | 475 | unnamed protein product [Vitis vinifera] |
Swiss-Prot | Q3E9A4 | 0 | 79 | 521 | 31 | 465 | GLYT5_ARATH RecName: Full=Probable glycosyltransferase At5g20260 |
RefSeq | XP_002263848.1 | 0 | 134 | 521 | 6 | 394 | PREDICTED: hypothetical protein [Vitis vinifera] |
Metabolic Pathways | |||
---|---|---|---|
Pathway Name | Reaction | EC | Protein Name |
xylogalacturonan biosynthesis | RXN-9589 | EC-2.4.2.41 | xylogalacturonan β-1,3-xylosyltransferase |